Skip to content

AngioDynamics ANGO Total Equity

Total Equity at other companies

Abbott logo
AbbottABT
$52.06B+6.7%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$24.13B-4.4%
TFX
TeleflexTFX
$3.08B-24.7%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.63B+13.9%
ICU Medical logo
ICU MedicalICUI
$2.11B+6.3%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's total equity?
AngioDynamics (ANGO) reported total equity of $173.36M in Q4 2025.
How has AngioDynamics's total equity changed year-over-year?
AngioDynamics's total equity decreased by 6.7% year-over-year, from $185.87M to $173.36M.
What is the long-term trend for AngioDynamics's total equity?
Over 4 years (2021 to 2025), AngioDynamics's total equity has grown at a -19.7% compound annual growth rate (CAGR), from $439.46M to $182.97M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.